HomeCompareRDSMY vs RYLD

RDSMY vs RYLD: Dividend Comparison 2026

RDSMY yields 29.34% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RDSMY wins by $259.66M in total portfolio value
10 years
RDSMY
RDSMY
● Live price
29.34%
Share price
$33.85
Annual div
$9.93
5Y div CAGR
42%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$259.71M
Annual income
$216,211,959.52
Full RDSMY calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — RDSMY vs RYLD

📍 RDSMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDSMYRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDSMY + RYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDSMY pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDSMY
Annual income on $10K today (after 15% tax)
$2,493.58/yr
After 10yr DRIP, annual income (after tax)
$183,780,165.59/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, RDSMY beats the other by $183,777,966.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDSMY + RYLD for your $10,000?

RDSMY: 50%RYLD: 50%
100% RYLD50/50100% RDSMY
Portfolio after 10yr
$129.88M
Annual income
$108,107,273.43/yr
Blended yield
83.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RDSMY right now

RDSMY
Analyst Ratings
2
Buy
Consensus: Buy
RYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDSMY buys
0
RYLD buys
0
No recent congressional trades found for RDSMY or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDSMYRYLD
Forward yield29.34%12.14%
Annual dividend / share$9.93$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR42%0%
Portfolio after 10y$259.71M$44.5K
Annual income after 10y$216,211,959.52$2,587.35
Total dividends collected$256.08M$18.8K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RDSMY vs RYLD ($10,000, DRIP)

YearRDSMY PortfolioRDSMY Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$14,866$4,165.74$11,914$1,213.65+$3.0KRDSMY
2$24,125$8,218.32$14,099$1,351.30+$10.0KRDSMY
3$43,513$17,699.56$16,580$1,494.55+$26.9KRDSMY
4$88,926$42,366.66$19,384$1,642.61+$69.5KRDSMY
5$210,055$114,904.40$22,535$1,794.70+$187.5KRDSMY
6$584,961$360,202.96$26,063$1,950.00+$558.9KRDSMY
7$1,957,119$1,331,210.45$29,995$2,107.69+$1.93MRDSMY
8$8,004,850$5,910,732.36$34,361$2,266.99+$7.97MRDSMY
9$40,648,692$32,083,502.25$39,194$2,427.12+$40.61MRDSMY
10$259,706,060$216,211,959.52$44,525$2,587.35+$259.66MRDSMY

RDSMY vs RYLD: Complete Analysis 2026

RDSMYStock

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

Full RDSMY Calculator →

RYLDETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this RDSMY vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDSMY vs SCHDRDSMY vs JEPIRDSMY vs ORDSMY vs KORDSMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.